Obesity and chronic intestinal inflammation are already well documented in the literature [52–54], as well as their consequences in reducing insulin sensitivity and increased glucose uptake [55,56]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.